SFM
PALI icon

Sphera Funds Management’s Palisade Bio PALI Stock Holding History

Sphera Funds Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.72M Buy
2,257,106
+523,635
+30% +$1.03M 0.62% 52
2026
Q1 		$3.03M Buy
1,733,471
+1,549,371
+842% +$2.82M 0.48% 65
2025
Q4 		$433K Buy
+184,100
New +$354K 0.08% 91

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sphera Funds Management's PALI Position: Q2 2026 in Review

Sphera Funds Management increased its Palisade Bio (PALI) stake by 30% in Q2 2026, buying an estimated $1.03M and bringing the position to 2,257,106 shares worth $4.72M. The position accounts for 0.62% of the portfolio, ranked #52.

Sphera Funds Management first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Sphera Funds Management held 2,257,106 shares of Palisade Bio worth $4.72M as of Q2 2026.
  • Sphera Funds Management bought 523,635 Palisade Bio shares in Q2 2026, an estimated $1.03M.
  • Palisade Bio made up 0.62% of Sphera Funds Management's portfolio in Q2 2026, its #52 holding.
  • Sphera Funds Management first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.